Related Experiment Video
Updated: May 30, 2026

Stimulation of Notch Signaling in Mouse Osteoclast Precursors
Published on: February 28, 2017
Therapeutic promise and challenges of targeting DLL4/NOTCH1
1Department of Molecular Biology, Genentech, Inc, South San Francisco, CA 94080, USA. minhong@gene.com.
Abstract:
DLL4-mediated NOTCH1 signaling represents an essential pathway for vascular development and has emerged as an attractive target for angiogenesis-based cancer therapies. However, newly reported toxicity findings raise safety concerns of chronic pathway blockade. Lessons learned from the development of γ-secretase inhibitors (GSIs) might offer insights into how to safely harness this important signaling pathway.
Insights
DLL4-NOTCH1 signaling is crucial for blood vessel growth and cancer therapy. New research explores safety concerns and lessons from gamma-secretase inhibitors to guide future treatments.
Area of Science:
- Molecular Biology
- Oncology
- Developmental Biology
Background:
- DLL4-mediated NOTCH1 signaling is vital for vascular development.
- This pathway is a promising target for anti-angiogenesis cancer therapies.
- Concerns exist regarding the safety of chronic blockade of this pathway.
Purpose of the Study:
- To review the role of DLL4-NOTCH1 signaling in vascular development.
- To discuss the potential and challenges of targeting this pathway in cancer therapy.
- To explore insights from gamma-secretase inhibitor development for safe pathway modulation.
Main Methods:
- Literature review and analysis of existing research on DLL4-NOTCH1 signaling.
- Examination of toxicity data from gamma-secretase inhibitor (GSI) studies.
- Synthesis of findings to propose strategies for safe pathway targeting.
Main Results:
- DLL4-NOTCH1 signaling is essential for angiogenesis and tumor growth.
- Chronic inhibition of this pathway can lead to significant toxicities.
- GSIs targeting NOTCH signaling have shown both efficacy and safety issues.
Conclusions:
- Understanding the nuances of DLL4-NOTCH1 signaling is critical for effective cancer therapy.
- Lessons from GSI development may inform strategies to mitigate toxicity.
- Careful modulation, rather than complete blockade, may be key to safely harnessing this pathway for therapeutic benefit.
More Related Videos
Related Concept Videos
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Canonical Wnt Signaling Pathway
Hedgehog Signaling Pathway
Regulation of Angiogenesis and Blood Supply

